Status:
ACTIVE_NOT_RECRUITING
Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects (≤ 45 Years) Hospitalized for an Ischaemic Stroke
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Stroke
Cannabis Use
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Incidence of strokes has increased these last 20 years in young population. This rise could be linked to alcohol, tobacco or drug use like cannabis. Cannabis has previously been descripted as a potent...
Eligibility Criteria
Inclusion
- Subject between 18 and 45 years old
- Stroke confirmed by medical imaging
- Written informed consent (subject, nearby or emergency procedure)
- Subject affiliate to a local healthcare insurance office
- For female of childbearing potential, an adequate contraceptive measur
Exclusion
- Subject with psychiatric disorder, unable to understand the study or cooperate
- Subject under guardianship or forfeiture of liberty
- Pregnant or breastfeeding woman
- Subject in period of exclusion due to another study or still in follow-up of an interventional study
Key Trial Info
Start Date :
January 11 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 11 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03379857
Start Date
January 11 2018
End Date
January 11 2025
Last Update
February 20 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Jean Minjoz
Besançon, France, 25030
2
Unite Neuro-Vasculaire
Colmar, France, 68024
3
Chu Bocage
Dijon, France, 21079
4
C.H. G. Muller
Mulhouse, France, 68070